Improvement on conventional constant current DC iontophoresis: a study using constant conductance AC iontophoresis.
The purpose of the present study was to compare conventional constant direct current (DC) transdermal iontophoresis with a new constant conductance alternating current (AC) iontophoresis method. The new method was developed with the intent of reducing flux drift during iontophoresis and minimizing skin-to-skin variability. The constant conductance AC iontophoresis studies involved three electrical components: (1) an initial applied potential used to decrease the human epidermal membrane (HEM) electrical resistance to a target level of either 1.5 or 3.0 k Omega cm(2), (2) an applied 50 Hz square-wave AC with a variable potential adjusted to maintain the HEM conductance at the target level during the transport study, and (3) a low voltage DC offset of 0 (passive), 0.25, or 0.40 V applied simultaneously with the AC to assist permeant transport. Current densities of 0.13 and 0.26 mA/cm(2) were chosen for the conventional constant current DC iontophoresis studies. Mannitol was used as the probe permeant for all studies. The constant current DC studies showed significant increases in mannitol flux with time during a given experiment and large skin-to-skin variability. Compared to the constant current DC experiments, the mannitol flux remained more constant during the constant conductance AC iontophoresis and skin-to-skin variability was significantly reduced. On a mechanistic level, changes in the transport properties during constant current DC iontophoresis indicate changes in the membrane parameters such as porosity, effective pore size, and/or pore surface charge density during the conventional method of iontophoresis. The results from the constant conductance AC iontophoresis transport studies imply that this method effectively maintains the membrane parameters that affect transport at a constant state this providing for a relatively constant permanent flux.
Zhu
Honggang
H
30 S 2000 E, Rm 201, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA. hzhu@m.cc.utah.edu
Li
S Kevin
SK
Peck
Kendall D
KD
Miller
David J
DJ
Higuchi
William I
WI
D001692:Biological Transport; D016503:Drug Delivery Systems; D004553:Electric Conductivity; D004817:Epidermis / Q000378:metabolism; D005712:Galvanic Skin Response / Q000502:physiology*; D006801:Humans; D007478:Iontophoresis / Q000379:methods*; D008353:Mannitol / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008566:Membranes / Q000378:metabolism; D010539:Permeability; D016062:Porosity; D013997:Time Factors
D008353:Mannitol